Two conformational forms of target-bound iC3b that distinctively bind complement receptors 1 and 2 and two specific monoclonal antibodies

References

• Janssen BJ, Huizinga EG, Raaijmakers HC, Roos A, Daha MR, Ekdahl KN, Structures of complement component C3 provide insights into the function and evolution of immunity. Nature. 2005;437:505–11.
   PubMed Web of Science ®Google Scholar
• Janssen BJ, Christodoulidou A, McCarthy A, Lambris JD, Gros P. Structure of C3b reveals conformational changes that underlie complement activity. Nature. 2006;444:213–6.
   PubMed Web of Science ®Google Scholar
• Janssen BJ, Gros P. Conformational complexity of complement component C3. Adv Exp Med Biol. 2006;586:291–312.
   Google Scholar
• Janssen BJ, Gros P. Structural insights into the central complement component C3. Mol Immunol. 2007;44:3–10.
   PubMed Web of Science ®Google Scholar
• Gros P, Milder FJ, Janssen BJ. Complement driven by conformational changes. Nat Rev Immunol. 2008;8:48–58.
   PubMed Web of Science ®Google Scholar
• Nilsson B, Svensson KE, Borwell P, Nilsson UR. Production of mouse monoclonal antibodies that detect distinct neoantigenic epitopes on bound C3b and iC3b but not on the corresponding soluble fragments. Mol Immunol. 1987;24:487–94.
   Google Scholar
• Nilsson B, Grossberger D, Ekdahl KN, Riegert P, Becherer D, Nilsson UR, Conformational differences between surface-bound and fluid-phase complement-component-C3 fragments: Epitope mapping by cDNA expression. Biochem J. 1992;282:715–21.
   Google Scholar
• Nilsson B, Ekdahl KN, Avila D, Nilsson UR, Lambris JD. Neoantigens in complement component C3 as detected by monoclonal antibodies. Mapping of the recognized epitopes by synthetic peptides. Biochem J. 1990;268:55–61.
   Google Scholar
• Ekdahl KN, Nilsson UR, Nilsson B. Inhibition of factor I by diisopropylfluorophosphate. Evidence of conformational changes in factor I induced by C3b and additional studies of the specificity of factor I. J Immunol. 1990;144:4269–74.
   Google Scholar
• Fearon D. Cellular receptors for fragments of the third component of complement. Immunol Today. 1984;5:105–10.
   Google Scholar
• Wong WW, Cahill JM, Rosen MD, Kennedy CA, Bonnaccio ET, Morris MJ, Structure of the human CR1 gene. J Exp Med. 1989;169:847–63.
   Google Scholar
• Toothaker LE, Henjes AJ, Weis JJ. Variability of CR2 gene products is due to alternative exon usage and different CR2 alleles. J Immunol. 1989;142:3668–75.
   Google Scholar
• Fujisako A, Harley JB, Frank MB, Gruner BA, Frazier B, Holers VM. Genomic organization and polymorphisms of the human C3d/Epstein-Barr virus receptor. J Biol Chem. 1989;264:2118–25.
   Google Scholar
• Hammer CH, Wirtz GH, Renfer L, Gresham HD, Tack BF. Large scale isolation of functionally active components of the human complement system. J Biol Chem. 1981;256:3995–4006.
   PubMed Web of Science ®Google Scholar
• Fearon DT. Purification of C3b inactivator and demonstration of its two polypeptide chain structure. J Immunol. 1977;119:1248–52.
   Google Scholar
• Nilsson U, Müller-Eberhard H. Isolation of beta IF-globulin from human serum and its characterization as the fifth component of complement. J Exp Med. 1965;122:277–98.
   PubMed Web of Science ®Google Scholar
• Nilsson UR. Deposition of C3b/iC3b leads to the concealment of antigens, immunoglobulins and bound C1q in complement-activating immune complexes. Mol Immunol. 2001;38:151–60.
   Google Scholar
• Alsenz J, Becherer D, Nilsson B, Lambris JD. Structural and functional analysis of C3 using monoclonal antibodies. Curr Top Microbiol Immunol. 1990;152:235–48.
   Google Scholar
• de Bruijn MH, Fey GH. Human complement component C3: cDNA coding sequence and derived primary structure. Proc Natl Acad Sci U S A. 1985;82:708–12.
   PubMed Web of Science ®Google Scholar
• Kusano M, Choi NH, Tomita M, Yamamoto K, Migita S, Sekiya T, Nucleotide sequence of cDNA and derived amino acid sequence of rabbit complement component C3 alpha-chain. Immunol Invest. 1986;15:365–78.
   Web of Science ®Google Scholar
• Nilsson B, Ekdahl KN, Svensson KE, Bjelle A, Nilsson UR. Distinctive expression of neoantigenic C3(D) epitopes on bound C3 following activation and binding to different target surfaces in normal and pathological human sera. Mol Immunol. 1989;26:383–90.
   Google Scholar